Method for detecting related substances of R-ketamine hydrochloride

Through high-performance liquid chromatography and gradient elution system, the problem that R-ketamine hydrochloride detection method in the existing technology cannot effectively separate and detect related substances, and the localization and quantitative research on impurities in R-ketamine hydrochloride is achieved, ensuring that Quality and safety of R-ketamine hydrochloride preparations.

CN119064483APending Publication Date: 2024-12-03NHWA PHARMA CORPORATION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310649016.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-02
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing R-ketamine hydrochloride detection methods cannot effectively isolate and detect all related substances, resulting in the inability to ensure the quality and safety of R-ketamine hydrochloride.

Method used

Using high-performance liquid chromatography, a gradient elution system of C18 column and phosphate buffer-acetonitrile was used to optimize the chromatographic conditions to improve the retention ability and peak response of impurities, and quantitative study on the localization of impurities in R-ketamine hydrochloride was achieved.

Benefits of technology

Effectively monitor the content of related substances in R-ketamine hydrochloride, improve the accuracy and reliability of detection, and ensure the quality and safety of R-ketamine hydrochloride preparations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004264387020000011
    Figure BDA0004264387020000011
  • Figure BDA0004264387020000021
    Figure BDA0004264387020000021
  • Figure BDA0004264387020000051
    Figure BDA0004264387020000051
Patent Text Reader

Abstract

The invention belongs to the technical field of pharmaceutical analysis, and particularly relates to a method for detecting related substances of R-ketamine hydrochloride, which adopts high performance liquid chromatography, and the chromatographic conditions are as follows: gradient elution is carried out by adopting a mobile phase A and a mobile phase B as mixed mobile phases; wherein the mobile phase A and the mobile phase B are mixed solutions of phosphate buffer and acetonitrile. By adopting the detection method disclosed by the invention, the detected impurities are more, the retention capability of main components and each impurity in the mobile phase system is stronger, the peak response is higher, all compounds can be effectively separated, and related substances in the R-ketamine hydrochloride can be better monitored.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pharmaceutical analysis, and particularly relates to a method for detecting R-ketamine hydrochloride related substances. Background Art

[0002] Ketamine hydrochloride is a racemic mixture of R-ketamine hydrochloride and S-ketamine hydrochloride, which has multiple pharmacological effects such as anesthesia, analgesia, antidepressant, anticonvulsant, neuroprotection, and induction of psychosis. Studies have shown that R-ketamine has stronger and more lasting antidepressant effects than S-ketamine in animal models of depression, and R-ketamine has no obvious side effects and abuse potential of psychotropic drugs, and is of great development value.

[0003] Arketamine Hydrochloride, chemical name is (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride, and its structural formula is as follows:

[0004]

[0005] At present, there are few literature reports on the detection methods of R-ketamine hydrochloride-related substances. Only the detection methods of ketamine hydrochloride-related substances included in the Chinese Pharmacopoeia (ChP), the European Pharmacopoeia (EP), the United States Pharmacopoeia (USP) and the British Pharmacopoeia (BP) are provided for reference. However, the detection methods of the pharmacopoeias have major defects and cannot separate and detect all R-ketamine hydrochloride-related substances. In addition, the impurity retention time is short and the response is weak, which cannot guarantee the quality and safety of R-ketamine hydrochloride.

[0006] The study of related substances is an extremely important project in drug quality research. Its content not only directly reflects the purity of the drug, but also has important safety significance. In order to ensure the safety and effectiveness of R-ketamine hydrochloride preparations, it is necessary to study, detect and control the related substances of the raw materials. According to the synthetic process route of this product, the related substances are mainly intermediates, reaction by-products and degradation products in the production process.

[0007] The present invention develops a new detection method for R-ketamine hydrochloride-related substances based on the prior art, which can realize the localization and quantitative study of impurities in R-ketamine hydrochloride, and lays a foundation for the quality evaluation of R-ketamine hydrochloride preparations. Summary of the invention

[0008] The purpose of the present invention is to provide a method for detecting related substances of R-ketamine hydrochloride on the basis of the prior art. The method detects many impurities, the retention capacity of the main component and each impurity in the mobile phase system is strong, the peak response is high, and each compound can be effectively separated, so that the content of related substances in R-ketamine hydrochloride can be better monitored.

[0009] To achieve the above object, the present invention provides the following technical solutions:

[0010] A method for detecting related substances of R-ketamine hydrochloride, the method adopts high performance liquid chromatography, the chromatographic column is C 18 The column is gradient eluted with phosphate buffer-acetonitrile as the mobile phase, the pH value of the phosphate buffer is 7 to 8, preferably the pH value is 7.3 to 7.7, and the related substances include the following substances:

[0011]

[0012] Furthermore, the chromatographic column of the present invention is a chromatographic column with octadecylsilane bonded silica as a filler, preferably SHIMADZU Shim-pack GIST C 18 Column, the chromatographic column specifications are 4.6×150mm, 5μm.

[0013] Further, the chromatographic conditions include: detection wavelength: 210-220 nm, flow rate: 0.8-1.2 ml / min, column temperature: 25-35° C., injection volume: 10-50 μl, injector temperature: 2-15° C.;

[0014] Preferably, the detection wavelength is 213-217 nm, the flow rate is 0.9-1.1 ml / min, the column temperature is 27-32° C., the injection volume is 15-25 μl, and the injector temperature is 5-10° C.;

[0015] Preferably, the detection wavelength is 215 nm, the flow rate is 1.0 ml / min, the column temperature is 30° C., the injection volume is 20 μl, and the injector temperature is 8° C.

[0016] Furthermore, the phosphate buffer contains triethylamine at a volume concentration of 0.01% to 0.1%; preferably, the phosphate buffer contains triethylamine at a volume concentration of 0.05%.

[0017] Furthermore, the pH value of the phosphate buffer is 7.5.

[0018] Furthermore, the phosphate is selected from a mixture of one or more of diammonium hydrogen phosphate and dipotassium hydrogen phosphate, preferably diammonium hydrogen phosphate.

[0019] Furthermore, the volume ratio of phosphate buffer to acetonitrile in the mobile phase A is (70-90):(10-30), preferably (78-82):(18-22); the volume ratio of phosphate buffer to acetonitrile in the mobile phase B is (10-30):(70-90), preferably (18-22):(78-82).

[0020] Furthermore, the volume ratio of phosphate buffer to acetonitrile in the mobile phase A is 80:20; the volume ratio of phosphate buffer to acetonitrile in the mobile phase B is 20:80.

[0021] Furthermore, the detection step includes:

[0022] (1) Solution preparation: prepare blank solution, system suitability solution, test solution and control solution respectively;

[0023] (2) Determination method: After the system is stable, inject blank solution, system suitability solution, test solution and control solution respectively, and record the chromatogram.

[0024] Further, a method for detecting related substances of R-ketamine hydrochloride:

[0025] The blank solution is mobile phase A;

[0026] The system suitability solution: take appropriate amounts of R-ketamine hydrochloride and impurity A, B, C, D, E, F reference substances, place them in a volumetric flask, add blank solution to dissolve and dilute to the scale, and shake well;

[0027] The test solution: Take an appropriate amount of the test sample, place it in a volumetric flask, add blank solution to dissolve and dilute to the scale, and shake well;

[0028] The control solution: Take an appropriate amount of the test solution, place it in a volumetric flask, add blank solution to dilute to the scale, and shake well.

[0029] Further, the mobile phase gradient elution procedure is as follows

[0030] Time (minutes) Mobile phase A (volume %) Mobile phase B (volume %) 0 70-90 10-30 30 20-40 60-80 35 20-40 60-80 36 70-90 10-30 45 70-90 10-30

[0031] Preferably, the mobile phase gradient elution procedure is as follows

[0032] Time (minutes) Mobile phase A (volume %) Mobile phase B (volume %) 0 80 20 30 30 70 35 30 70 36 80 20 45 80 20 .

[0033] Furthermore, the detection method is used to detect related substances in R-ketamine hydrochloride raw materials or preparations.

[0034] Beneficial Effects

[0035] The technical solution of the present invention has the following advantages:

[0036] (1) The mobile phase system used in the present invention can effectively improve the retention capacity of the main components and various impurities, and the response of each component is relatively high and the peak shape is relatively good, which solves the problem that the retention capacity of R-ketamine hydrochloride and its impurities is weak, the response is low and the peak shape is poor in the general buffer salt mobile phase system, and can effectively detect the related substances in R-ketamine hydrochloride, which is of great significance for the quality control of R-ketamine hydrochloride.

[0037] (2) The present invention adopts a method of controlling the temperature of the sampler under chromatographic conditions to solve the problem that impurity A is easily hydrolyzed in a high-water phase solvent, while avoiding the influence of the solvent effect on impurity detection caused by using a high organic phase as a solvent after the sample solution enters the liquid chromatograph. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 This is the blank solution spectrum of the present invention.

[0039] Figure 2 This is a solution spectrum of the system applicability of the present invention.

[0040] Figure 3 This is the sample solution spectrum of the present invention. DETAILED DESCRIPTION

[0041] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention, and should not be construed as limiting the scope of protection of the present invention. All technical schemes implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.

[0042] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.

[0043] Example 1: System Applicability and Specificity

[0044] (1) Instruments: high performance liquid chromatograph, electronic analytical balance, pH meter, etc.

[0045] (2) Solution preparation:

[0046] Take an appropriate amount of the product for test solution, weigh it accurately, add mobile phase A to dissolve and dilute it to make a solution containing about 1 mg per 1 ml.

[0047] Control solution: Accurately measure an appropriate amount of the test solution and dilute it with mobile phase A to make a solution containing approximately 1 μg per 1 ml.

[0048] For the reference substance stock solution, accurately weigh appropriate amounts of impurity A, B, C, D, E, and F reference substances, dissolve and dilute them with acetonitrile to prepare a solution containing approximately 1 mg per 1 ml; accurately weigh appropriate amounts of R-ketamine hydrochloride reference substance, dissolve and dilute them with mobile phase A to prepare a solution containing approximately 1 mg per 1 ml.

[0049] For the reference substance solution, accurately measure an appropriate amount of the reference substance stock solution, place it in the same volumetric flask, and dilute it with mobile phase A to make a solution containing about 1.5 μg of impurity A, about 2 μg of impurities B and C, and about 1 μg of impurities D, E, F, and R-ketamine hydrochloride per 1 ml.

[0050] System suitability solution: Accurately weigh an appropriate amount of R-ketamine hydrochloride reference substance, add an appropriate amount of each impurity reference substance stock solution, place in the same volumetric flask, dissolve and dilute with mobile phase A to make a solution containing approximately 1 mg of R-ketamine hydrochloride, approximately 1.5 μg of impurity A, approximately 2 μg of impurities B and C, and approximately 1 μg of impurities D, E, and F per 1 ml.

[0051] For the positioning solution, accurately measure an appropriate amount of the reference substance stock solution and dilute it with mobile phase A to make a solution containing approximately 10 μg of each substance per 1 ml.

[0052] Acceptable criteria: When injecting blank solution (mobile phase A), there should be no interfering peaks; when continuously injecting 6-pin reference solution, the RSD of the peak area of ​​6 pins should be ≤10%; when injecting system suitability solution, the separation between each peak should meet the requirements; when the system meets the requirements, inject the test solution, reference solution and each positioning solution; when the sequence ends, inject 1-pin reference solution again, and the RSD of the peak area of ​​7 pins should be ≤10%.

[0053] Table 1 System suitability test results

[0054]

[0055] Table 2 Specificity test results

[0056]

[0057] The system suitability test results show that the RSD of the peak area of ​​6 and 7 for the reference product is less than 10%, and the system suitability is good. The blank solvent peak does not interfere with the determination of the impurities of this product, and the separation between the impurity peaks and between the impurity peak and the main peak meets the requirements.

[0058] Example 2: Destructive test

[0059] ① Acid destruction

[0060] Weigh about 10 mg of this product accurately, place it in a 10 ml volumetric flask, add 1 ml of 1 mol / L hydrochloric acid solution, place it at room temperature for 5 days, adjust it to neutral with 1 mol / L sodium hydroxide solution, dissolve it with mobile phase A and dilute it to the scale as the acid destruction solution. At the same time, carry out a blank test as the blank solution for acid destruction.

[0061] ②Alkali destruction

[0062] Weigh about 10 mg of this product accurately, place it in a 10 ml volumetric flask, add 1 ml of 1 mol / L sodium hydroxide solution, place it at room temperature for 5 days, adjust it to neutral with 1 mol / L hydrochloric acid solution, dissolve it with mobile phase A and dilute it to the scale as the alkaline destruction solution. At the same time, carry out a blank test as the blank solution for alkaline destruction.

[0063] ③ Oxidative damage

[0064] Mobile phase A as diluent: accurately weigh about 10 mg of this product, place it in a 10 ml volumetric flask, add 1 ml of 3% hydrogen peroxide solution, leave it at room temperature for 1 day, dissolve it with mobile phase A and dilute it to the scale, as oxidation destruction solution-1. At the same time, carry out a blank test, as oxidation destruction blank solution-1.

[0065] Water as diluent: Accurately weigh about 10 mg of this product, place it in a 10 ml volumetric flask, add 1 ml of 3% hydrogen peroxide solution, leave it at room temperature for 1 day, dissolve it in water and dilute it to the scale, as oxidation destruction solution-2. At the same time, carry out a blank test, as oxidation destruction blank solution-2.

[0066] ④High temperature damage

[0067] Accurately weigh about 10 mg of this product and place it in a 10 ml volumetric flask. Place it in an oven at 120°C for 48 hours and then dissolve it in mobile phase A and dilute to the scale to prepare the high temperature destruction solution.

[0068] ⑤ Light damage

[0069] Accurately weigh about 10 mg of this product and place it in a 10 ml volumetric flask. Place it in a light box with a cool white fluorescent lamp (5000±500 Lux) and a near-ultraviolet fluorescent lamp (90 μW / cm2) turned on simultaneously for 10 days, then take it out, dissolve it with mobile phase A and dilute it to the scale to use as the light destruction solution.

[0070] Accurately measure 20 μl each of blank solution, control solution, system suitability solution, test solution, reference solution, and acid, alkali, oxidation, high temperature, and light-damaged solutions, and inject them into the liquid chromatograph to record the chromatogram.

[0071] Acceptable standards: The degradation products produced by this product after being destroyed by acid, alkali, oxidation, high temperature and light can be well detected, and the separation degree between each degradation product and the main component peak should meet the requirements; the purity of the main peak is not less than 0.990; the residual rate of the main drug after destruction is not less than 80%, and the percentage of total materials should be between 95% and 105%.

[0072] Table 3 Summary of destructive test results

[0073] Test Name Acid damage Alkali damage Oxidative damage* High temperature damage Light damage Impurity D(%) Not detected Not detected 0.03 Not detected Not detected Impurity E(%) Not detected Not detected Not detected Not detected Not detected Impurity B(%) Not detected Not detected Not detected Not detected Not detected Impurity C(%) Not detected Not detected Not detected Not detected Not detected Impurity F(%) Not detected Not detected Not detected Not detected Not detected Impurity A(%) Not detected Not detected Not detected Not detected Not detected Maximum unknown impurity (%) 0.01 Not detected 0.12 Not detected Not detected Total unknown impurities (%) 0.01 Not detected 0.28 Not detected Not detected Main drug remaining rate (%) 98.53 99.44 99.39 99.07 99.41 Material balance (%) 98.54 99.44 99.70 99.07 99.41

[0074] Note: "*": Oxidative damage data refers to the test data with water as diluent

[0075] Table 4 Peak purity of main peak in destruction test

[0076] Test Name Purity Similarity Peak purity threshold Impurities Unbroken 0.999999 0.999998 Not Detected Acid damage 1.000000 0.999998 Not Detected Alkali damage 1.000000 0.999998 Not Detected Oxidative damage 1.000000 0.999999 Not Detected High temperature damage 0.999999 0.999998 Not Detected Light damage 1.000000 0.999999 Not Detected

[0077] Conclusion: 1. It is relatively stable under acid (1mol / L HCl), alkali (1mol / L NaOH), high temperature (120℃) and light damage conditions and basically does not degrade.

[0078] 2. This product is oxidized (3% H 2 O 2 ) for one day, the oxidative destruction solution prepared by dissolving and diluting with water contained less degradation impurities, and after being placed for about 6 hours, the content of degradation impurities did not change significantly. 2 O 2 After 1 day of storage, a relatively high unknown impurity (RRT = 0.68) was generated in the solution. After about 6 hours of storage, the content of the impurity increased significantly. According to LC-MS analysis, the [M+H]+ of the impurity had m / z = 254.0941, and the fitted chemical formula was C 13 H 16 ClNO 2 , than R-ketamine hydrochloride base (chemical formula is C 13 H 16 ClNO) has an extra O, which may be the oxidation product of R-ketamine hydrochloride. By comparison, R-ketamine hydrochloride is oxidized (3% H 2 O 2 ) is stable under the condition of destruction, mobile phase A can promote H 2 O 2 Destructive effects of R-ketamine hydrochloride.

[0079] 3. Under the destruction conditions, each impurity can be well separated from the main component, and the materials before and after destruction are basically balanced; the main peak purity of each destroyed sample and undestroyed sample was analyzed, and the results all met the requirements.

[0080] Example 3: Sensitivity

[0081] Accurately weigh the appropriate amount of impurity A, B, C, D, E, and F reference substances, dissolve and dilute with acetonitrile to make a solution containing about 1 mg per 1 ml; accurately weigh the appropriate amount of R-ketamine hydrochloride reference substance, dissolve and dilute with mobile phase A to make a solution containing about 1 mg per 1 ml, and gradually dilute to a low concentration. Accurately measure 20 μl of the solution to be tested and inject it into the liquid chromatograph. When the signal-to-noise ratio is about 10:1, the amount of sample injected is the quantitative limit; when the signal-to-noise ratio is about 3:1, the amount of sample injected is the detection limit; the quantitative limit solution is repeatedly injected 6 times, and the RSD of the peak area is required to be ≤10%.

[0082] Table 5 Quantitation limit determination results

[0083]

[0084]

[0085] Table 6 Detection limit determination results

[0086]

[0087]

[0088] The test results show that the quantitative limit concentration and detection limit concentration of each impurity and R-ketamine hydrochloride are low, and can be well detected and accurately quantified; the quantitative limit solution was repeatedly injected 6 times, and the RSD of the peak area was less than 10%, indicating that the method has a high sensitivity.

[0089] Example 4: Linearity and Range

[0090] Take 7 concentration points within the range of the quantitative limit and the 1.0% limit, perform linear regression on the peak area y against the concentration x, calculate the linear equation and correlation coefficient, and the correlation coefficient r should be greater than 0.995.

[0091] Table 7 Impurity D, impurity E linearity and range determination results

[0092]

[0093] Table 8 Impurity B, R-ketamine hydrochloride linearity and range determination results

[0094]

[0095] Table 9 Impurity C, impurity F linearity and range determination results

[0096]

[0097] Table 10 Impurity A linearity and range determination results

[0098]

[0099] From the test results, it can be seen that the concentrations of impurity D, impurity E, impurity B, R-ketamine hydrochloride, impurity C, impurity F and impurity A are in the ranges of 0.102-10.209μg / ml, 0.102-10.178μg / ml, 0.101-10.079μg / ml, 0.104-10.380μg / ml, 0.108-10.785μg / ml, 0.101-10.136μg / ml and 0.220-10.994μg / ml, respectively. There is a good linear relationship between the peak area and the concentration, and the correlation coefficients are all greater than 0.995.

[0100] Example 5: Correction Factor

[0101] Different people used different instruments and different detectors (ultraviolet, diode array) to perform linear determination of R-ketamine hydrochloride and various impurities. The slope of the linear equation of R-ketamine hydrochloride was divided by the slope of the linear equation of the impurity to calculate the correction factor of each impurity relative to R-ketamine hydrochloride.

[0102] Table 11 Determination results of each impurity correction factor

[0103]

[0104] From the test results, it can be seen that the correction factors of impurities D, E, B, C, F and A relative to R-ketamine hydrochloride are 1.26, 1.10, 0.96, 0.76, 0.88 and 0.95 respectively. The correction factors of impurities E, B and A are between 0.9 and 1.1, and can be quantified by the principal component self-control method without correction factors. The correction factors of impurities C and F are slightly lower than 1.0, and the quantitative results of the principal component self-control method without correction factors are overestimated. Impurity D can be quantified by the principal component self-control method with correction factors.

[0105] Example 6: Accuracy

[0106] Accuracy is achieved by measuring the recovery rate between the actual concentration and theoretical concentration of each component. It is required that the recovery rate of each component in the solution with the quantitative limit concentration, 50% limit concentration, 100% limit concentration and 200% limit concentration recovery rate should be between 80% and 120%.

[0107] Table 12 Impurity D recovery determination results

[0108]

[0109]

[0110] Table 13 Impurity E recovery rate determination results

[0111]

[0112] Table 14 Impurity B recovery determination results

[0113]

[0114] Table 15 Impurity C recovery determination results

[0115]

[0116]

[0117] Table 16 Impurity F recovery determination results

[0118]

[0119] Table 17 Impurity A recovery determination results

[0120]

[0121]

[0122] From the test results, it can be seen that the recovery rates of solutions with different concentrations of impurity D, impurity E, impurity B, impurity C, impurity F and impurity A are all between 80% and 120%, indicating that the accuracy of the method is good.

[0123] Example 7: Precision

[0124] Repeatability is achieved by measuring the RSD of the test results of 6 sample solutions, and the RSD should be less than 15%.

[0125] Table 18 Repeatability test results

[0126]

[0127] The test results show that the contents of the known impurities, the largest unknown impurity and the total impurities in the repeated determination of the related substances in 6 samples were basically consistent, and the RSD was less than 15%, indicating that the method has good repeatability.

[0128] The intermediate precision is tested by different experimenters at different times using different instruments on 12 samples of the test product, and the RSD should be less than 15%.

[0129] Table 19 Summary of precision test results

[0130]

[0131] It can be seen from the test results that different experimenters used different instruments at different times to test the relevant substances in 12 sampled test samples. The results of the determination of the known impurities, the maximum unknown impurity and the total impurity content in the sampled test sample solutions were basically consistent, and the RSD was less than 15%, indicating that the intermediate precision was good.

[0132] Example 8: Solution Stability

[0133] Place the system suitability solution, reference solution, sampled test solution and control solution in an injector controlled at 8°C, accurately measure 20 μl at different time points and inject into the liquid chromatograph, and record the chromatogram. Statistic the changes in the peak area of ​​each impurity, and calculate the content and RSD of known impurities, the largest unknown impurity and total impurities in the sampled test solution, requiring the peak area RSD ≤ 10% and the content RSD ≤ 15%.

[0134] Table 20 Peak area determination results of reference solution

[0135] Time (h) Impurity D Impurity E Impurity B R-Ketamine Hydrochloride Impurity C Impurity F Impurity A 0 30689 35364 79326 40598 110112 45244 63673 10 30459 35740 78982 40903 110960 45231 63250 25 30246 35865 79464 40473 113090 45089 62875 39 30492 35747 79301 40618 114852 45013 60035 58 30527 35915 79359 40784 117496 45328 57127 average value 30483 35726 79286 40675 113302 45181 61392 RSD(%) 0.52 0.60 0.23 0.41 2.64 0.28 4.53

[0136] Table 21 Peak area measurement results of control solution

[0137] Time (h) R-Ketamine Hydrochloride 0 42158 10 42143 25 42446 39 42269 58 42213 average value 42246 RSD(%) 0.29

[0138] Table 22 Test results of the test solution

[0139]

[0140] From the test results, we can see that the related substance determination solution of this product is placed under the condition of 8℃ temperature control in the injector for 58 hours, and there is no obvious change in the peak area of ​​the reference solution and the reference solution. The known impurities, maximum unknown impurities and total impurities content measured in the test solution are basically consistent, indicating that the related substance determination solution of this product is stable after being placed under the condition of 8℃ temperature control in the injector for 58 hours.

[0141] Example 9: Durability

[0142] The tolerance of the measurement results was investigated by slight changes in the chromatographic condition parameters.

[0143] Table 23 Parameters of chromatographic condition changes

[0144]

[0145] (1) Effect of wavelength change on the determination of related substances

[0146] After the system suitability meets the requirements, accurately measure 20 μl of the reference solution, the sample solution and the reference solution, respectively, and inject them into the liquid chromatograph at wavelengths of 210 nm, 215 nm and 220 nm to record the chromatogram. The content of each known impurity in the sample solution is calculated by the external standard method, and the unknown impurities are calculated by the main component self-reference method.

[0147] Table 24 Effect of wavelength change on system suitability solution determination results

[0148]

[0149]

[0150] Table 25 Effect of wavelength change on the measurement results of sample solution

[0151]

[0152] The related substances of this product were determined under three different wavelength conditions of 210nm, 215nm and 220nm. The retention time, theoretical plate number, tailing factor and separation degree of each peak in the system suitability solution did not change significantly. The contents of known impurities, maximum unknown impurities and total impurities in the sample solution were basically the same, indicating that the change of wavelength within a small range basically does not affect the determination results of related substances of this product.

[0153] (2) Effect of flow rate changes on the determination of related substances

[0154] After the system suitability is met, accurately measure 20μl of the reference solution, the sample solution and the reference solution, inject them into the liquid chromatograph at flow rates of 0.8ml / min, 1.0ml / min and 1.2ml / min, and record the chromatogram. The content of each known impurity in the sample solution is calculated by the external standard method, and the unknown impurities are calculated by the main component self-reference method.

[0155] Table 26 Effect of flow rate change on system suitability solution determination results

[0156]

[0157]

[0158] Table 27 Effect of flow rate change on the test results of sample solution

[0159]

[0160] Note: The data of “flow rate 1.0 ml / min” are the same as those of “215 nm in (1)”.

[0161] The related substances of this product were determined under three different flow rate conditions of 0.8ml / min, 1.0ml / min, and 1.2ml / min. The retention time, theoretical plate number, and separation degree of each peak in the system suitability solution decreased with the increase of flow rate, and the tailing factor did not change significantly. The contents of known impurities, maximum unknown impurities, and total impurities in the sample solution were basically the same, indicating that changes in flow rate within a small range basically do not affect the determination results of related substances of this product.

[0162] (3) Effect of column temperature changes on the determination of related substances

[0163] After the system suitability is met, accurately measure 20 μl of the reference solution, the sample solution and the reference solution, respectively, and inject them into the liquid chromatograph at column temperatures of 25°C, 30°C and 35°C, and record the chromatogram. The content of each known impurity in the sample solution is calculated by the external standard method, and the unknown impurities are calculated by the main component self-reference method.

[0164] Table 28 Effect of column temperature change on system suitability solution determination results

[0165]

[0166]

[0167] Table 29 Effect of column temperature change on the determination results of sample solution

[0168]

[0169] Note: The data of “column temperature 30°C” are the same as the data of “215 nm in (1)”.

[0170] The related substances of this product were determined under three different column temperature conditions: 25℃, 30℃, and 35℃. The retention time, theoretical plate number, and separation degree of each peak in the system suitability solution were slightly different, and the tailing factor did not change significantly. The contents of known impurities, maximum unknown impurities, and total impurities in the sample solution were basically the same, indicating that changes in column temperature within a small range would not affect the determination results of related substances of this product.

[0171] (4) Effect of pH changes on the determination of related substances

[0172] After the system suitability is met, accurately measure 20 μl of the reference solution, the sample solution and the reference solution, respectively, and inject them into the liquid chromatograph under the condition that the pH value of the buffer in the mobile phase is 7.3, 7.5, and 7.7, and record the chromatogram. The content of each known impurity in the sample solution is calculated by the external standard method, and the unknown impurities are calculated by the main component self-reference method.

[0173] Table 30 Effect of pH change on system suitability solution determination results

[0174]

[0175]

[0176] Table 31 Effect of pH changes on the results of the test solution

[0177]

[0178] Note: The data of “pH value 7.5” are the same as the data of “215 nm in (1)”.

[0179] The related substances of this product were determined under the conditions of buffer pH values ​​of 7.3, 7.5, and 7.7 in the mobile phase. The retention time, theoretical plate number, and separation degree of each peak in the system suitability solution were slightly different, and the tailing factor did not change significantly. The contents of known impurities, maximum unknown impurities, and total impurities in the sample solution were basically the same, indicating that the change of buffer pH value in the mobile phase within a small range basically does not affect the determination results of related substances of this product.

[0180] (5) Effect of changes in mobile phase ratio on the determination of related substances

[0181] After the system suitability is met, accurately measure 20 μl of each of the reference solution, the sample solution and the reference solution, and inject them into the liquid chromatograph under the conditions of buffer-acetonitrile as mobile phase ①A82:18; B20:80, mobile phase ②A78:22; B20:80, mobile phase ③A80:20; B20:80, mobile phase ④A80:20; B22:78, mobile phase ⑤A80:20; B18:82, and record the chromatogram. The content of each known impurity in the sample solution is calculated by the external standard method, and the unknown impurities are calculated by the main component self-reference method.

[0182] Table 32 Effect of mobile phase ratio change on system suitability solution determination results

[0183]

[0184] Table 33 Effect of changes in mobile phase ratio on the determination results of sample solution

[0185]

[0186] Note: The data of “mobile phase ③” are the same as those of “215 nm in (1)”.

[0187] The related substances of this product were determined under different mobile phase ratios. The results showed that the retention time, theoretical plate number, and separation degree of each peak in the system suitability solution decreased with the increase of the organic phase ratio in mobile phase A or mobile phase B, and the tailing factor did not change significantly. Under the above mobile phase ratio conditions, the contents of known impurities, maximum unknown impurities, and total impurities in the sample solution were basically the same, indicating that changes in the mobile phase ratio within a small range basically do not affect the determination results of related substances of this product.

[0188] (6) Effects of different chromatographic columns on the determination of related substances

[0189] The following chromatographic columns were used for the experiment: ① SHIMADZU Shim-pack GIST C18, (4.6×150mm, 5μm) C18-512 ② SHIMADZU Shim-pack GIST C18, (4.6×150mm, 5μm) C18-517 ③ SHIMADZU Shim-pack GIST C18, (4.6×150mm, 5μm) C18-518.

[0190] After the system suitability is met, accurately measure 20 μl of each of the reference solution, the sample solution and the reference solution, and inject them into the liquid chromatograph under the conditions of the above-mentioned chromatographic columns ①, ② and ③, and record the chromatogram. The content of each known impurity in the sample solution is calculated by the external standard method, and the unknown impurities are calculated by the main component self-reference method.

[0191] Table 34 Effect of different chromatographic columns on the results of system suitability solution determination

[0192]

[0193]

[0194] Table 35 Effect of different chromatographic columns on the determination results of sample solution

[0195]

[0196] Note: The data of “Chromatographic column ②” are the same as the data of “215 nm in (1)”.

[0197] The related substances of this product were determined using SHIMADZU Shim-pack GIST C18 (4.6×150mm, 5μm) chromatographic columns with different numbers. The retention time, theoretical plate number, tailing factor and separation degree of each peak in the system suitability solution did not change significantly. The contents of known impurities, maximum unknown impurities and total impurities in the sample solution were basically the same, indicating that the use of different numbered chromatographic columns of the same brand basically does not affect the determination results of related substances of this product.

[0198] In summary, the system applicability and specificity, sensitivity, linearity and range, accuracy, precision, solution stability and durability of this method all meet the requirements, indicating that this method is suitable for the detection of related substances of R-ketamine hydrochloride.

[0199] The above is a description of a specific embodiment of the present invention. It should be understood that the present invention is not limited to the above embodiment, and the above embodiment and description are only for illustrating the principle of the present invention.

[0200] Those skilled in the art may make various non-substantial changes and improvements to the present invention without departing from the concept of the present invention, all of which fall within the scope of protection claimed by the present invention.

Claims

1. A method for detecting related substances of R-ketamine hydrochloride, characterized in that: The detection method adopts high performance liquid chromatography, and the chromatographic column is C 18 The column is gradient eluted with phosphate buffer-acetonitrile as the mobile phase, the pH value of the phosphate buffer is 7 to 8, preferably the pH value is 7.3 to 7.7, and the related substances include the following substances:

2. The detection method according to claim 1, characterized in that: The chromatographic column used was SHIMADZU Shim-packGIST C 18 Column, the chromatographic column specifications are 4.6×150mm, 5μm.

3. The detection method according to claim 1, characterized in that: The chromatographic conditions include: detection wavelength: 210-220nm, flow rate: 0.8-1.2ml / min, column temperature: 25-35°C, injection volume: 10-50μl, injection temperature: 2-15°C; preferably, the detection wavelength is 215nm, the flow rate is 1.0ml / min, the column temperature is 30°C, the injection volume is 20μl, and the injection temperature is 8°C.

4. The detection method according to claim 1, characterized in that: The phosphate buffer contains triethylamine at a volume concentration of 0.01% to 0.1%; preferably, the phosphate buffer contains triethylamine at a volume concentration of 0.05%.

5. The detection method according to claim 1, characterized in that: The phosphate is selected from a mixture of one or more of diammonium hydrogen phosphate and dipotassium hydrogen phosphate, preferably diammonium hydrogen phosphate.

6. The detection method according to claim 1, characterized in that: The volume ratio of phosphate buffer to acetonitrile in the mobile phase A is (70-90):(10-30), preferably (78-82):(18-22); the volume ratio of phosphate buffer to acetonitrile in the mobile phase B is (10-30):(70-90), preferably (18-22):(78-82).

7. The detection method according to claim 6, characterized in that: The detection steps include: (1) Solution preparation: prepare blank solution, system suitability solution, test solution and control solution respectively; (2) Determination method: After the system is stable, inject blank solution, system suitability solution, test solution and control solution respectively, and record the chromatogram.

8. The detection method according to claim 7, characterized in that: The blank solution is mobile phase A; The system suitability solution: take appropriate amounts of R-ketamine hydrochloride and impurity A, B, C, D, E, F reference substances, place them in a volumetric flask, add blank solution to dissolve and dilute to the scale, and shake well; The test solution: Take an appropriate amount of the test sample, place it in a volumetric flask, add blank solution to dissolve and dilute to the scale, and shake well; The control solution: Take an appropriate amount of the test solution, place it in a volumetric flask, add blank solution to dilute to the scale, and shake well.

9. The detection method according to any one of claims 1 to 8, characterized in that: The mobile phase gradient elution procedure is as follows Preferably, the mobile phase gradient elution procedure is as follows 。 10. Use of the detection method according to any one of claims 1 to 9 for detecting related substances in R-ketamine hydrochloride bulk drug or preparation.